Gerrard Terlouw

Gerrard Terlouw is a highly experienced professional in the pharmaceutical and biotechnology sectors, currently serving as the VP Head of Business Development Europe, Emerging Markets and JANZ at Viatris since January 2024. Additionally, Gerrard holds a position on the Board of Directors at Berlin Cures Holding AG. With a career spanning over two decades at Novartis, Gerrard has contributed significantly in various roles, including Global Head of Business Development & Licensing in Immunology & Dermatology, where Gerrard developed comprehensive licensing strategies and secured a robust deal pipeline. Gerrard's earlier positions at Novartis also include leadership in negotiations for integrated hospital care and project management in transplantation and oncology. Gerrard's educational background includes advanced degrees in Toxicology, Pharmacy, and Business Management from prestigious institutions such as ETH Zürich, Utrecht University, and Harvard Business School.